Important Safety Information   |   Full Prescribing Information

XERMELO® (telotristat ethyl) Carcinoid Syndrome Diarrhea Treatment

Now Approved
a

XERMELO™ is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

Learn how XERMELO™ helps reduce carcinoid syndrome diarrhea Learn how to get financial support for XERMELO™ through the LexCares program Sign up to hear about XERMELO™ from a neuroendocrine tumor specialist

Social Image

Important Safety Information and Indication

Important Safety Information and Indication

Important Safety Information

  • XERMELO may cause constipation which can be serious. You should stop taking XERMELO if severe constipation or severe, persistent, or worsening abdominal pain develops. Talk to your doctor if you have these symptoms
  • The most common side effects of XERMELO include nausea, headache, increase in hepatic enzymes, depression, flatulence, decreased appetite, swelling of your hands and feet, and fever
  • Talk to your doctor about all medicines you are taking as some may interact with XERMELO

Indication

XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for Carcinoid Syndrome diarrhea in adults who are not adequately controlled by SSA therapy.

For more information about XERMELO, talk to your doctor or see Full Prescribing Information.

You may report an adverse event related to Lexicon products by calling 1-844-LEX-PHAR (1-844-539-7427)  (US only). If you prefer, you may contact the US Food and Drug Administration (FDA) directly. The FDA has established a reporting service known as MedWatch where healthcare professionals and consumers can report serious problems they suspect may be associated with the drugs and medical devices they prescribe, dispense, or use. Visit MedWatch or call 1-800-FDA-1088.